Natixis Advisors
THC icon

Natixis Advisors’s Tenet Healthcare THC Stock Holding History

Natixis Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89M Buy
47,502
+1,795
+4% +$330K 0.01% 760
2026
Q1 		$8.63M Buy
45,707
+9,774
+27% +$2.06M 0.01% 701
2025
Q4 		$7.14M Sell
35,933
-3,050
-8% -$616K 0.01% 726
2025
Q3 		$7.92M Sell
38,983
-547
-1% -$97K 0.01% 721
2025
Q2 		$6.96M Buy
39,530
+3,767
+11% +$567K 0.01% 740
2025
Q1 		$4.81M Buy
35,763
+18,123
+103% +$2.39M 0.01% 828
2024
Q4 		$2.23M Sell
17,640
-22,308
-56% -$3.32M ﹤0.01% 1064
2024
Q3 		$6.64M Buy
39,948
+6,491
+19% +$982K 0.01% 755
2024
Q2 		$4.45M Sell
33,457
-378
-1% -$45.5K 0.01% 826
2024
Q1 		$3.56M Buy
33,835
+1,654
+5% +$149K 0.01% 884
2023
Q4 		$2.43M Sell
32,181
-68,164
-68% -$4.32M 0.01% 945
2023
Q3 		$6.61M Sell
100,345
-16,497
-14% -$1.23M 0.02% 623
2023
Q2 		$9.51M Buy
116,842
+9,330
+9% +$664K 0.03% 541
2023
Q1 		$6.39M Buy
107,512
+18,806
+21% +$1.05M 0.02% 625
2022
Q4 		$4.33M Buy
88,706
+52,114
+142% +$2.41M 0.02% 719
2022
Q3 		$1.89M Buy
36,592
+21,048
+135% +$1.25M 0.01% 907
2022
Q2 		$817K Sell
15,544
-3,668
-19% -$255K ﹤0.01% 1166
2022
Q1 		$1.65M Buy
+19,212
New +$1.58M 0.01% 1012
2015
Q4 		– Sell
-11,885
Closed -$439K – 1016
2015
Q3 		$439K Sell
11,885
-1,851
-13% -$95.6K 0.01% 912
2015
Q2 		$795K Sell
13,736
-1,414
-9% -$72.2K 0.01% 821
2015
Q1 		$750K Buy
15,150
+3,179
+27% +$149K 0.01% 846
2014
Q4 		$607K Buy
+11,971
New +$626K 0.01% 887

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Natixis Advisors's THC Position: Q2 2026 in Review

Natixis Advisors increased its Tenet Healthcare (THC) stake by 3.9% in Q2 2026, buying an estimated $330K and bringing the position to 47,502 shares worth $8.89M. The position accounts for 0.01% of the portfolio, ranked #760.

Natixis Advisors first reported a position in THC in Q4 2014 and has held it in 22 quarters since. The position peaked at $9.51M in Q2 2023. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Natixis Advisors held 47,502 shares of Tenet Healthcare worth $8.89M as of Q2 2026.
  • Natixis Advisors bought 1,795 Tenet Healthcare shares in Q2 2026, an estimated $330K.
  • Tenet Healthcare made up 0.01% of Natixis Advisors's portfolio in Q2 2026, its #760 holding.
  • Natixis Advisors first reported a position in Tenet Healthcare in Q4 2014 and has held it in 22 quarters since.
  • Natixis Advisors's Tenet Healthcare position peaked at $9.51M in Q2 2023.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.